Category: misconduct investigations

Whistleblower gets court backing in defamation case — but at a cost

It’s been a long and winding road for a whistleblower at Indiana University, South Bend.

After Mark Fox, a professor of management and entrepreneurship accused two business professors of plagiarism in 2012, a university investigation found one of the two men — Douglas Agbetsiafa, the former chair of the economics department — guilty of plagiarism, and terminated him in January 2014. The other professor was cleared of any wrongdoing — then sued Fox for defamation in June, 2014.

Fox won the case, but it dragged on. More than two years later, in December 2016, the Indiana Supreme Court declined to hear an appeal.

Fox told us:

Continue reading Whistleblower gets court backing in defamation case — but at a cost

Columbia University probe prompts retraction of cardiovascular paper

A journal has retracted a 2011 study at the request of Columbia University.

According to Jeanine D’Armiento, the study’s last author, the newly retracted paper in Clinical Science contained a figure from a Journal of Hypertension paper published by the same authors earlier that year. 

First and corresponding author Joseph George told Retraction Watch the error was unintentional. A Columbia spokesperson sent us this statement: Continue reading Columbia University probe prompts retraction of cardiovascular paper

A Harvard whistleblower was subjected to a forced mental exam. Here’s why.

Last March, a PhD student at Harvard filed a misconduct allegation against his mentor, a prominent stem cell researcher. Three months later, he was taken from his home by police in the middle of the night for a forced psychiatric evaluation.

How did this happen? Continue reading A Harvard whistleblower was subjected to a forced mental exam. Here’s why.

Breast cancer studies by fired Pfizer employee retracted

Last year, Pfizer fired one of its scientists following an investigation that ended with requests for retraction of five of her studies. Now, two of the five papers, which were first flagged on PubPeer, have been retracted.

One notice cites the Pfizer investigation, which found that cancer researcher Min-Jean Yin had included duplicated images in all five papers. Yin is the last author on both retracted papers.

Here’s the first notice from Clinical Cancer Research, which says most or all of the questioned images appear to be duplicates, and Pfizer — who sponsored the study and requested the retraction — can’t find the originals:
Continue reading Breast cancer studies by fired Pfizer employee retracted

Japan group earns 4th retraction following investigation

Researchers in Japan have issued their fourth retraction, noting that the same figures were used to depict different experimental conditions.

The group lost two papers in 2015 for the same reason, following a misconduct investigation at Oita University in Japan. Last year, the same group notched another retraction, and pegged the responsibility for the problematic figures on first author Satoshi Hagiwara.

Now, the group has published a fourth retraction in the European Journal of Pharmacology; the latest notice doesn’t identify a culprit. All four retracted papers list Hagiwara as first author.

Here’s the latest retraction notice: Continue reading Japan group earns 4th retraction following investigation

Journal retracts all papers by education researcher, bringing his total to 21

jaasepA journal has followed through on its promise to retract all articles by an education researcher, after an investigation raised questions about the validity of the data in some of his work with children with special needs.

The latest notice — which includes a list of 11 papers — brings the total number of retractions for Noel Kok Hwee Chia to 21.

Last spring, The Journal of the American Academy of Special Education Professionals (JAASEP) pulled nine articles by Chia that were the subject of an investigation at the National Institute of Education in Singapore, part of Nanyang Technological University, where he worked until April. As we reported in June, editors explained in a 3,000-word notice that they planned to pull every article that Chia had published in JAASEP.

The new retraction notice quotes from the reasoning presented in the previous one, from last spring:

Continue reading Journal retracts all papers by education researcher, bringing his total to 21

Prominent researcher in Taiwan loses another paper for image duplication

In November, a vice president at an institution in Taiwan retracted a hotly debated cancer paper from Nature Cell Biology, citing image problems including duplications. Now, the Journal of Biological Chemistry has done the same, again citing image duplications.

There are a few things to note about the latest retraction: One, the last author is again Kuo Min-liang — who holds an appointment at National Taiwan University (NTU), and is also a vice president at Kaohsiung Medical University in Taiwan. Kuo is currently facing allegations that he accepted bribes to add co-authors to his papers; NTU told us it is investigating the latest retraction in the Journal of Biological Chemistry, including Kuo.

The other notable feature of the retraction is the notice itself, which lists a remarkable number of duplicated images. Take a look:

Continue reading Prominent researcher in Taiwan loses another paper for image duplication

ORI misconduct findings fell in 2016. Why? We ask the director

Kathy Partin

Every year, the U.S. Office of Research Integrity (ORI) issues a series of findings against researchers it has determined committed fraud of some kind. In contrast to many agencies such as the National Science Foundation and around the world, the ORI names the offender, describes the offense, and states the penalty – often a temporary ban on federal funding, for instance.

2016 brought a lot of changes to the agency – it was director Kathy Partin‘s first year, which brought reports of staff unrest (and threats to resign). But there was another notable feature of last year, as we and others have noted – the agency issued only seven findings of misconduct, compared to 14 in 2015 and 11 the year before. (Once a sanction has lifted the finding disappears from the ORI site; here is a count of the agency’s activity from previous years.) We spoke to Partin about this relative lack of action from the agency last year.

Retraction Watch: Why are there so much fewer notices this year than last?  Continue reading ORI misconduct findings fell in 2016. Why? We ask the director

Researcher loses 4th paper flagged by misconduct probe

A researcher in Germany has logged her fourth retraction following an investigation by her former employer that found evidence of scientific misconduct.

The latest retraction for Tina Wenz in the Journal of Applied Physiology mentions the probe at the University of Cologne in Germany, which recommended retracting six of her papers. One had already been retracted by the time the report was released; last month, we reported that two others had been pulled. Now, we’ve come across a fourth.

Here’s the latest retraction notice: Continue reading Researcher loses 4th paper flagged by misconduct probe

Cancer researcher in Germany loses multiple papers after misconduct finding

A pathology journal is retracting two papers after an investigation at the last author’s institution in Germany found evidence of scientific misconduct.

The notice for both papers cites an investigation involving Regine Schneider-Stock, who studies cancer biology at the Friedrich Alexander-University Erlangen-Nuremberg (FAU). Meanwhile, another 2005 paper that lists Schneider-Stock as the first author was retracted in October, noting evidence of image manipulation.

The most recent retractions, from the American Journal of Pathology, note that FAU declined to provide the journal with details of its investigation beyond a prepared statement:

Continue reading Cancer researcher in Germany loses multiple papers after misconduct finding